Buy Zynerba Pharmaceuticals Stock | ZYNE Stock Price & Latest News | Public
ZYNE

Zynerba Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap

    About ZYNE

    Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions. It offers Zygel product which formulated as a permeation-enha...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.26
    -0.52
    -0.78
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.35

    Actual EPS
    Q4 2020

    Stats

    Market Cap$133,94M
    Volume17,17k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$7.45
    1 Year Low$2.55
    Open$4.59
    High$4.60
    Low$4.45

    Buy any stock with any amount of money.

    Download the App
    Download the app